IP Library Granted Patent US 11,202,806
Granted Patent B2
US 11,202,806 · App. 16/342,617 · Granted Dec 21, 2021

Amoeba therapeutic dressings, biomaterials, and solutions

Inventors: Justin J. Baker (Cleveland, OH); Peter H. Gingras (Cleveland, OH)
Assignee: VISCUS BIOLOGICS, LLC
A61K35/68A01N63/00A61F13/00063A61K9/0014A61K9/7007A61K47/46A61L15/325A61P17/02A61P31/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,202,806
App. No.
16/342,617
Granted
Dec 21, 2021
Kind
B2
Abstract

A method of treating or preventing a microbial infection in a subject is described. The method includes contacting a microorganism within the subject with a composition comprising one or more species of amoebae of the genus Willaertia . Antibiotic wound dressings and kits for providing amoeba for treatment or prevention of microbial infection in a subject are also described.

Claims (12)

1. A method of treating or preventing a microbial infection in a subject, comprising: contacting a microorganism within the subject with a composition comprising one or more species of amoebae of the genus Willaertia.

2. The method of claim 1 , wherein the composition comprises one or more species of amoebae of the genus Willaertia in a pharmaceutically acceptable carrier.

3. The method of claim 1 , wherein the subject has a skin wound, and the amoebas are administered to the skin wound.

4. The method of claim 3 , wherein the skin wound is a chronic wound.

5. The method of claim 3 , further comprising placing a wound dressing onto the skin wound of the subject.

6. The method of claim 1 , wherein the one or more species of amoebae is a Willaertia magna species of amoebas.

7. The method of claim 1 , wherein the microbial infection is a bacterial infection.

8. The method of claim 7 , wherein the bacteria are antibiotic-resistant.

9. The method of claim 7 , wherein the amoebas are administered from the wound dressing.

10. The method of claim 1 , wherein the amoebas are administered in cyst form.

11. The method of claim 1 , further comprising contacting the wound with collagen.

12. The method of claim 1 , further comprising co-administering a therapeutic agent to the subject.

Assignments (2)
CONFIRMATORY LICENSE Recorded Dec 20, 2022
From: VISCUS BIOLOGICS, LLC.
To: UNITED STATES GOVERNMENT
Reel/Frame 062184/0255 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2021
From: BAKER, JUSTIN J.; GINGRAS, PETER H.
To: VISCUS BIOLOGICS, LLC
Reel/Frame 057773/0435 →
Continuity (2)
Provisional Application 62409406 · Oct 18, 2016
Related Publication 20190231827A1 · Aug 1, 2019